These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

532 related articles for article (PubMed ID: 32024694)

  • 21. The src homology 2 and phosphotyrosine binding domains of the ShcC adaptor protein function as inhibitors of mitogenic signaling by the epidermal growth factor receptor.
    O'Bryan JP; Lambert QT; Der CJ
    J Biol Chem; 1998 Aug; 273(32):20431-7. PubMed ID: 9685397
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro phosphorylation of the epidermal growth factor receptor autophosphorylation domain by c-src: identification of phosphorylation sites and c-src SH2 domain binding sites.
    Lombardo CR; Consler TG; Kassel DB
    Biochemistry; 1995 Dec; 34(50):16456-66. PubMed ID: 8845374
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epidermal growth factor receptor (HER1) tyrosine kinase inhibitor ZD1839 (Iressa) inhibits HER2/neu (erbB2)-overexpressing breast cancer cells in vitro and in vivo.
    Moulder SL; Yakes FM; Muthuswamy SK; Bianco R; Simpson JF; Arteaga CL
    Cancer Res; 2001 Dec; 61(24):8887-95. PubMed ID: 11751413
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Crystal structures of peptide complexes of the amino-terminal SH2 domain of the Syp tyrosine phosphatase.
    Lee CH; Kominos D; Jacques S; Margolis B; Schlessinger J; Shoelson SE; Kuriyan J
    Structure; 1994 May; 2(5):423-38. PubMed ID: 7521735
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protein Kinase A (PKA) Phosphorylation of Shp2 Protein Inhibits Its Phosphatase Activity and Modulates Ligand Specificity.
    Burmeister BT; Wang L; Gold MG; Skidgel RA; O'Bryan JP; Carnegie GK
    J Biol Chem; 2015 May; 290(19):12058-67. PubMed ID: 25802336
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TNF-alpha induces tyrosine phosphorylation and recruitment of the Src homology protein-tyrosine phosphatase 2 to the gp130 signal-transducing subunit of the IL-6 receptor complex.
    Bode JG; Schweigart J; Kehrmann J; Ehlting C; Schaper F; Heinrich PC; Häussinger D
    J Immunol; 2003 Jul; 171(1):257-66. PubMed ID: 12817006
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A critical role for phosphoinositide 3-kinase upstream of Gab1 and SHP2 in the activation of ras and mitogen-activated protein kinases by epidermal growth factor.
    Yart A; Laffargue M; Mayeux P; Chretien S; Peres C; Tonks N; Roche S; Payrastre B; Chap H; Raynal P
    J Biol Chem; 2001 Mar; 276(12):8856-64. PubMed ID: 11134009
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SHP1 and SHP2 protein-tyrosine phosphatases associate with betac after interleukin-3-induced receptor tyrosine phosphorylation. Identification of potential binding sites and substrates.
    Bone H; Dechert U; Jirik F; Schrader JW; Welham MJ
    J Biol Chem; 1997 May; 272(22):14470-6. PubMed ID: 9162089
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantitative assays for the measurement of HER1-HER2 heterodimerization and phosphorylation in cell lines and breast tumors: applications for diagnostics and targeted drug mechanism of action.
    DeFazio-Eli L; Strommen K; Dao-Pick T; Parry G; Goodman L; Winslow J
    Breast Cancer Res; 2011 Apr; 13(2):R44. PubMed ID: 21496232
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The protein tyrosine phosphatase, Shp2, is required for the complete activation of the RAS/MAPK pathway by brain-derived neurotrophic factor.
    Easton JB; Royer AR; Middlemas DS
    J Neurochem; 2006 May; 97(3):834-45. PubMed ID: 16573649
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Receptor tyrosine kinase ubiquitylation involves the dynamic regulation of Cbl-Spry2 by intersectin 1 and the Shp2 tyrosine phosphatase.
    Okur MN; Russo A; O'Bryan JP
    Mol Cell Biol; 2014 Jan; 34(2):271-9. PubMed ID: 24216759
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Requirement of SHP2 binding to Grb2-associated binder-1 for mitogen-activated protein kinase activation in response to lysophosphatidic acid and epidermal growth factor.
    Cunnick JM; Dorsey JF; Munoz-Antonia T; Mei L; Wu J
    J Biol Chem; 2000 May; 275(18):13842-8. PubMed ID: 10788507
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of Shp2 suppresses mutant EGFR-induced lung tumors in transgenic mouse model of lung adenocarcinoma.
    Schneeberger VE; Ren Y; Luetteke N; Huang Q; Chen L; Lawrence HR; Lawrence NJ; Haura EB; Koomen JM; Coppola D; Wu J
    Oncotarget; 2015 Mar; 6(8):6191-202. PubMed ID: 25730908
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epidermal growth factor receptors containing a single tyrosine in their C-terminal tail bind different effector molecules and are signaling-competent.
    Gill K; Macdonald-Obermann JL; Pike LJ
    J Biol Chem; 2017 Dec; 292(50):20744-20755. PubMed ID: 29074618
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phosphorylation of tyrosine 319 of the angiotensin II type 1 receptor mediates angiotensin II-induced trans-activation of the epidermal growth factor receptor.
    Seta K; Sadoshima J
    J Biol Chem; 2003 Mar; 278(11):9019-26. PubMed ID: 12522132
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tyrosine phosphatase SHP2 promotes breast cancer progression and maintains tumor-initiating cells via activation of key transcription factors and a positive feedback signaling loop.
    Aceto N; Sausgruber N; Brinkhaus H; Gaidatzis D; Martiny-Baron G; Mazzarol G; Confalonieri S; Quarto M; Hu G; Balwierz PJ; Pachkov M; Elledge SJ; van Nimwegen E; Stadler MB; Bentires-Alj M
    Nat Med; 2012 Mar; 18(4):529-37. PubMed ID: 22388088
    [TBL] [Abstract][Full Text] [Related]  

  • 37. EGF-receptor specificity for phosphotyrosine-primed substrates provides signal integration with Src.
    Begley MJ; Yun CH; Gewinner CA; Asara JM; Johnson JL; Coyle AJ; Eck MJ; Apostolou I; Cantley LC
    Nat Struct Mol Biol; 2015 Dec; 22(12):983-90. PubMed ID: 26551075
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel mode for neutrophil protease cathepsin G-mediated signaling: membrane shedding of epidermal growth factor is required for cardiomyocyte anoikis.
    Rafiq K; Hanscom M; Valerie K; Steinberg SF; Sabri A
    Circ Res; 2008 Jan; 102(1):32-41. PubMed ID: 17975113
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prolactin modulates phosphorylation, signaling and trafficking of epidermal growth factor receptor in human T47D breast cancer cells.
    Huang Y; Li X; Jiang J; Frank SJ
    Oncogene; 2006 Dec; 25(58):7565-76. PubMed ID: 16785991
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Src homology 2 domains enhance tyrosine phosphorylation
    Jadwin JA; Curran TG; Lafontaine AT; White FM; Mayer BJ
    J Biol Chem; 2018 Jan; 293(2):623-637. PubMed ID: 29162725
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.